https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-05-01 / Immunol. Invest. 2000 May;29(2):139-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-05-01 / Immunol. Invest. 2000 May;29(2):139-422000-05-01 00:00:002019-02-15 09:17:57Use of mild, whole body hyperthermia in cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-04-01 / Lancet 2000 Apr;355(9210):1119-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-04-01 / Lancet 2000 Apr;355(9210):1119-252000-04-01 00:00:002019-02-15 08:35:52Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-04-01 / Nat. Med. 2000 Apr;6(4):435-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-04-01 / Nat. Med. 2000 Apr;6(4):435-422000-04-01 00:00:002019-02-15 09:18:05HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-17 / Dtsch. Med. Wochenschr. 2000 Mar;125(11):317-92000-03-17 00:00:002000-03-17 00:00:00[Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-162000-03-01 00:00:002019-02-15 08:51:14Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-82000-02-01 00:00:002019-02-15 08:45:17Clinical applications of dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-152000-02-01 00:00:002019-02-15 09:22:30Newcastle disease virus (NDV): brief history of its oncolytic strains
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-152000-02-01 00:00:002019-02-15 08:51:15Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-111
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-1112000-02-01 00:00:002000-02-01 00:00:00Selenium and immunocompetence in patients with head and neck cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 2000 Jan;46(1):179-852000-01-01 00:00:002000-01-01 00:00:00Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment
